 PLYMOUTH MEETING, Pa., Feb. 14, 2022 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Companys fourth quarter and full year 2021 financial results on Monday, February 28, 2022. 